Literature DB >> 3080727

The production of soluble and cellular interleukin-2 receptors by cord blood mononuclear cells following in vitro activation.

D L Nelson, C C Kurman, M E Fritz, B Boutin, L A Rubin.   

Abstract

Cord blood mononuclear cells (CBMC) were investigated for their capacity to generate both cellular and soluble, supernatant interleukin-2 receptors (IL-2R) following cellular activation in vitro. Soluble IL-2R were measured in cell-free supernatants and in detergent-solubilized cell extracts with a "sandwich" enzyme-linked immunosorbent assay. CBMC and adult peripheral blood mononuclear cells were activated with phytohemagglutinin or the murine monoclonal antibody OKT3. CBMC and adult peripheral blood mononuclear cells generated cellular and soluble IL-2R in response to both activators. Peak values for supernatant IL-2R were observed on day 7, while peak values of cell-associated IL-2R occurred on day 5, followed by a decline on day 7. With the exception of supernatant IL-2R production induced by OKT3 stimulation, CBMC produced IL-2R in amounts comparable to adult mononuclear cells. Cord blood plasma also contained amounts of IL-2R comparable to that found in adult sera/plasma. Thus, CBMC appear largely immunocompetent with regard to the expression of IL-2R.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3080727     DOI: 10.1203/00006450-198602000-00008

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  8 in total

1.  Correlation of immunoregulatory function with cell phenotype in cord blood lymphocytes.

Authors:  G Kingsley; C Pitzalis; A P Waugh; G S Panayi
Journal:  Clin Exp Immunol       Date:  1988-07       Impact factor: 4.330

2.  Clinical relevance of raised soluble serum interleukin-2 receptor concentrations in cystic fibrosis.

Authors:  D Y Koller; M Götz
Journal:  Arch Dis Child       Date:  1993-01       Impact factor: 3.791

3.  Enhancement of antibody-dependent cellular cytotoxicity of neonatal cells by interleukin-2 (IL-2) and IL-12.

Authors:  Q H Nguyen; R L Roberts; B J Ank; S J Lin; C K Lau; E R Stiehm
Journal:  Clin Diagn Lab Immunol       Date:  1998-01

4.  Serum levels of soluble forms of T cell activation antigens CD27 and CD25 in systemic lupus erythematosus in relation with lymphocytes count and disease course.

Authors:  A J Swaak; R Q Hintzen; V Huysen; H G van den Brink; J T Smeenk
Journal:  Clin Rheumatol       Date:  1995-05       Impact factor: 2.980

5.  Interleukin-15 enhances cytotoxicity, receptor expression, and expansion of neonatal natural killer cells in long-term culture.

Authors:  Sunwoong S Choi; Vaninder S Chhabra; Quoc H Nguyen; Bonnie J Ank; E Richard Stiehm; Robert L Roberts
Journal:  Clin Diagn Lab Immunol       Date:  2004-09

6.  IL-2 receptor gene expression and IL-2 production by human preterm newborns' cells.

Authors:  H Bessler; L Sirota; I Notti; T Milo; M Djaldetti
Journal:  Clin Exp Immunol       Date:  1993-09       Impact factor: 4.330

7.  Increased cyclosporine sensitivity of T cells from cord blood compared with those from the adult.

Authors:  R M McDouall; A J Suitters; H Smith; M H Yacoub; M L Rose
Journal:  Clin Exp Immunol       Date:  1994-03       Impact factor: 4.330

8.  Biological significance of soluble IL-2 receptor.

Authors:  C Caruso; G Candore; D Cigna; A T Colucci; M A Modica
Journal:  Mediators Inflamm       Date:  1993       Impact factor: 4.711

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.